| Serial Number | 97313494 |
| Word Mark | SCANDION ONCOLOGY |
| Filing Date | Tuesday, March 15, 2022 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, February 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 20, 2024 |
| Goods and Services | Anti-cancer preparations; Anti-cancer preparations of chemical origin; Anti-cancer preparations from hormones and antagonists; Anti-cancer preparations of microbial origin; Anti-cancer preparations of plant origin; Compounds for treating cancer; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Medical preparations for the treatment of cancer; Chemical preparations for medical purposes for the treatment of cancer; Biochemical preparations for medical use for the treatment of cancer; Biological preparations for medical purposes for the treatment of cancer; Anti-cancer drugs; Antitumor drugs; Injectable pharmaceuticals for the treatment of cancer; Medicinal preparations and substances for the treatment of cancer; Medicines for human purposes for the treatment of cancer; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical compositions for the treatment of cancer; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for human use for the treatment of cancer; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceuticals for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Compounds for treating resistant cancers; Pharmaceutical preparations and substances for the treatment of treatment-resistant cancers |
| Goods and Services | Active chemical ingredients for use in the manufacture of anti-cancer drugs |
| Disclaimer with Predetermined Text | "ONCOLOGY" |
| Goods and Services | Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of oncology |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 21, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 21, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 21, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Scandion Oncology A/S |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | København Ø 2100 DK |
| Party Name | Scandion Oncology A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | København Ø 2100 DK |
| Event Date | Event Description |
| Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 20, 2024 | PUBLISHED FOR OPPOSITION |
| Thursday, February 1, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, February 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, February 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, January 18, 2024 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, January 12, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, January 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 30, 2023 | ASSIGNED TO LIE |
| Monday, June 26, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 24, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, March 24, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, December 26, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 26, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, December 26, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, December 26, 2022 | ASSIGNED TO EXAMINER |
| Monday, March 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 18, 2022 | NEW APPLICATION ENTERED |